2.
Comparison of mean and median survival of CRS+ HIPEC+EPIC versus chemotherapy groups (Ref 16)
| Treatment | Case No. | Survival (month) | |
| Mean | Median | ||
| CRS, cytoreductive surgery; HIPEC, hyperthermic intraperitoneal chemotherapy; EPIC, early postoperative intraperitoneal chemotherapy. P values were not provided. | |||
| Chemotherapy | 10 | 11.1 | 10.4 |
| CRS+HIPEC+EPIC | 7 | 20.5 | 15.3 |